ESPR – esperion therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Esperion (ESPR) Highlights Inclusion of Bempedoic Acid in 2026 ACC/AHA Dyslipidemia Guidelines [Yahoo! Finance]
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session [Yahoo! Finance]
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia
Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference [Yahoo! Finance]
Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: VANGUARD GROUP INC
Form 4 Esperion Therapeutics, For: Mar 17 Filed by: Looker Benjamin
Form 4 Esperion Therapeutics, For: Mar 17 Filed by: Koenig Sheldon L.
Form 4 Esperion Therapeutics, For: Mar 17 Filed by: Halladay Benjamin
Form 144 Esperion Therapeutics, Filed by: Halladay Benjamin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.